BioWorld - Friday, January 30, 2026

BioWorld Science

April 26, 2022

View Archived Issues

AMG-794, a CLDN6-targeting BiTE for treating lung and ovarian tumors

Read More

CDK4/6 inhibitor PRT-3645 prolongs survival in glioblastoma and brain-metastatic breast cancers

Read More

TNIK as novel therapeutic target in lung squamous cell carcinoma

Read More

ZLD-2218, a novel BRD4 inhibitor for the treatment of kidney fibrosis

Read More

Discovery of novel oridonin analogues as potent anticancer agents

Read More

BeiGene patents new MAP4K1 inhibitors

Read More

Duality Biologics divulges new ADCs for cancer

Read More

Shenzhen Salubris Pharmaceuticals presents GLP-1 receptor agonists

Read More

Jiangsu Chia Tai Tianqing Pharmaceutical researchers synthesize new AKT inhibitors

Read More

Origo Biopharma discloses new TGFBR1 inhibitors

Read More

Turnstone Biologics collaborates with University of Montreal for development of TIL therapy

Read More

Portage, NCI and Stimunity collaborate to advance STING agonists and anti-RAGE agents

Read More

AI Therapeutics acquires EntreChem's EC-8042 for pediatric cancers

Read More

Targeting CD166 overcomes platinum resistance in ovarian cancer

Read More

ViGeneron and Daiichi Sankyo enter follow-on collaboration for gene therapy for eye diseases

Read More

PAK4 inhibition enhances anti-PD-1 therapy in prostate cancer

Read More

Researchers develop gene-editing platform to edit mitochondrial DNA

Read More